Literature DB >> 18682550

1-[6-[[(17beta)-3-methoxyestra-1,3,5(10)-trien-17-yl]amino]hexyl]-1H-pyrrole-2,5-dione (U73122) selectively inhibits Kir3 and BK channels in a phospholipase C-independent fashion.

Angelika Klose1, Tobias Huth, Christian Alzheimer.   

Abstract

1-[6-[[(17beta)-3-methoxyestra-1,3,5(10)-trien-17-yl]amino]hexyl]-1H-pyrrole-2,5-dione (U73122) is widely used to inhibit phospholipase C (PLC)-mediated signaling, but we and others have also reported a PLC-independent block of Kir3 channels in native cells. To elaborate on this major side effect, we examined the action of U73122 and 1-[6-[[(17beta)-3-methoxyestra-1,3,5(10)-trien-17-yl]amino]hexyl]-2,5-pyrollidinedione (U73343), a structurally related but not PLC-inhibiting analog, on Kir1.1, Kir2.1, or Kir3.1/3.2 channels expressed in HEK293 cells. Both compounds (10 microM) displayed an unusual degree of selectivity for Kir3, superior even to that of tertiapin, which discriminates between Kir3 and Kir2 but also inhibits Kir1.1. Recordings from mutant Kir2 and Kir3 channels showed that U73122 is unlikely to block Kir3 by interfering with binding of phosphatidylinositol 4,5-bisphosphate, and U73122 did not seem to act like a pore blocker. U73122 and U73343 also unexpectedly suppressed Ca(2+)-activated K(+) channels of the large-conductance type (MaxiK, BK) in a PLC-independent fashion. In single-channel recordings, both compounds significantly decreased open probability of BK channels and slowed their ultrafast gating ("flickering") at very depolarized potentials. Alignment of the amino acid sequences of Kir3 and BK channels suggested that the highly selective effect of U73122/U73343 is mediated by a homologous domain within the long C-terminal ends. In fact, mutations in the C-terminal region of Kir2 and Kir3 channels significantly altered their sensitivity to the two compounds. Our data strongly caution against the use of U73122 when exploring signaling pathways involving Kir3 and BK channels. However, the apparent binding of U73122/U73343 to a common structural motif might be exploited to develop drugs selectively targeting Kir3 and BK channels.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18682550     DOI: 10.1124/mol.108.047837

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  10 in total

Review 1.  Structural insights into phospholipase C-β function.

Authors:  Angeline M Lyon; John J G Tesmer
Journal:  Mol Pharmacol       Date:  2013-07-23       Impact factor: 4.436

Review 2.  Side-effects of protein kinase inhibitors on ion channels.

Authors:  Youn Kyoung Son; Hongzoo Park; Amy L Firth; Won Sun Park
Journal:  J Biosci       Date:  2013-12       Impact factor: 1.826

3.  Direct modulation of TRPM4 and TRPM3 channels by the phospholipase C inhibitor U73122.

Authors:  Michael G Leitner; Niklas Michel; Marc Behrendt; Marlen Dierich; Sandeep Dembla; Bettina U Wilke; Maik Konrad; Moritz Lindner; Johannes Oberwinkler; Dominik Oliver
Journal:  Br J Pharmacol       Date:  2016-07-18       Impact factor: 8.739

4.  The phospholipase C inhibitor U73122 is a potent agonist of the polymodal transient receptor potential ankyrin type 1 (TRPA1) receptor channel.

Authors:  Cristian Neacsu; Susanne K Sauer; Peter W Reeh; Alexandru Babes
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-09-03       Impact factor: 3.000

5.  Direct activation of human phospholipase C by its well known inhibitor u73122.

Authors:  Ryan R Klein; David M Bourdon; Chester L Costales; Craig D Wagner; Wendy L White; Jon D Williams; Stephanie N Hicks; John Sondek; Dhiren R Thakker
Journal:  J Biol Chem       Date:  2011-01-25       Impact factor: 5.157

6.  Inhibition of phospholipase C disrupts cytoskeletal organization and gravitropic growth in Arabidopsis roots.

Authors:  Zornitza Andreeva; Deborah Barton; William J Armour; Min Y Li; Li-Fen Liao; Heather L McKellar; Kylie A Pethybridge; Jan Marc
Journal:  Planta       Date:  2010-08-29       Impact factor: 4.116

7.  Phospholipase C-independent effects of 3M3FBS in murine colon.

Authors:  Laura Dwyer; Hyun Jin Kim; Byoung Ho Koh; Sang Don Koh
Journal:  Eur J Pharmacol       Date:  2009-11-18       Impact factor: 4.432

Review 8.  Cardiac Potassium Channels: Physiological Insights for Targeted Therapy.

Authors:  Kamalan Jeevaratnam; Karan R Chadda; Christopher L-H Huang; A John Camm
Journal:  J Cardiovasc Pharmacol Ther       Date:  2017-09-25       Impact factor: 2.457

9.  Expression of the C-Terminal Domain of Phospholipase Cβ3 Inhibits Signaling via Gαq-Coupled Receptors and Transient Receptor Potential Channels.

Authors:  Gerald Thiel; Oliver G Rössler
Journal:  Int J Mol Sci       Date:  2022-08-24       Impact factor: 6.208

Review 10.  Pharmacological Modulation and (Patho)Physiological Roles of TRPM4 Channel-Part 1: Modulation of TRPM4.

Authors:  Zsigmond Máté Kovács; Csaba Dienes; Tamás Hézső; János Almássy; János Magyar; Tamás Bányász; Péter P Nánási; Balázs Horváth; Norbert Szentandrássy
Journal:  Pharmaceuticals (Basel)       Date:  2022-01-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.